(NCT01371357, NCT00102843, NCT00126347, NCT01950039, NCT04633044, and NCT06042270)
"Safe treatment requires ongoing care and monitoring by a trained healthcare professional." Federal regulators share that concern: the FDA has reported adverse events, some requiring hospitalization, tied to dosing errors with unapproved compounded versions
Ozempic requires intensive management involving regular monitoring and cannot be handled via telehealth, which is why Klinic in Norfolk focuses on approved weight loss treatments such as Wegovy, Oral Wegovy, Zepbound, and Foundayo, each tailored for telemedicine
Compounded are made by different manufacturers and may use different colors for their tablets or injection pens
holding a presence in the region